Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group

NCT00805428 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2008-12-09

No results posted yet for this study

Summary

Mucosal inflammation in patients with UC is the result of immunosuppression disturbance because decreasing number of regulatory T ly and activation IL 17

Conditions

Sponsors & Collaborators

  • Clinical Hospital Center, Split

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30

Countries

  • Croatia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00805428 on ClinicalTrials.gov